Home ETF List About

Portfolio Holdings Detail for ISIN IE00BFNM3G45
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSASU(USD) LSE
ETF TickerGPSA(GBP) LSE
ETF TickerSGAS(EUR) F
ETF TickerGPSA.LS(GBP) CXE
ETF TickerSASU.LS(USD) CXE
ETF TickerSASUz(USD) CXE
ETF TickerSGAS.DE(EUR) CXE
ETF TickerSASU.L(GBP) LSE
ETF TickerGPSA.L(GBP) LSE

Holdings detail for RMD

Stock NameResMed Inc
TickerRMD(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS7611521078
LEI529900T3QE5253CCXF22

Show aggregate RMD holdings

News associated with RMD

Contrasting ResMed (NYSE:RMD) & ImmuCell (NASDAQ:ICCC)
ImmuCell (NASDAQ:ICCC – Get Free Report) and ResMed (NYSE:RMD – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk. Profitability This table compares ImmuCell and ResMed’s net margins, return […] - 2025-09-15 04:58:43
ResMed (NYSE:RMD) Stock Rating Upgraded by CLSA
ResMed (NYSE:RMD – Get Free Report) was upgraded by equities research analysts at CLSA from a “hold” rating to an “outperform” rating in a report released on Tuesday, Marketbeat reports. Other equities research analysts have also issued reports about the stock. Wall Street Zen lowered shares of ResMed from a “buy” rating to a “hold” […] - 2025-09-04 02:12:56
Thursday's ETF with Unusual Volume: MTRA
The Invesco International Growth Focus ETF is seeing unusually high volume in afternoon trading Thursday, with over 150,000 shares traded versus three month average volume of about 27,000. Shares of MTRA were up about 0.1% on the day. Components of that ETF with the highest vo - 2025-08-28 13:08:23
ResMed Inc. (NYSE:RMD) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
ResMed Inc. (NYSE:RMD – Get Free Report) has been given an average recommendation of “Moderate Buy” by the sixteen brokerages that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and two have assigned a […] - 2025-08-22 02:42:57
MSTU, MTRA: Big ETF Inflows
Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the MSTU ETF, which added 27,460,000 units, or a 15.7% increase week over week. And on a percentage change basis, the ETF with the biggest increase - 2025-08-21 12:30:23
Atria Wealth Solutions Inc. Has $574,000 Stock Holdings in ResMed Inc. (NYSE:RMD)
Atria Wealth Solutions Inc. decreased its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 2.5% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 2,563 shares of the medical equipment provider’s stock after selling 65 shares during the period. Atria Wealth Solutions Inc.’s holdings in ResMed were worth $574,000 as of […] - 2025-08-14 05:04:56
ResMed Inc. (NYSE:RMD) Shares Sold by Cetera Investment Advisers
Cetera Investment Advisers trimmed its position in ResMed Inc. (NYSE:RMD – Free Report) by 4.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,003 shares of the medical equipment provider’s stock after selling 602 shares during the period. Cetera […] - 2025-08-07 04:34:54
ResMed (NYSE:RMD) Hits New 12-Month High After Analyst Upgrade
ResMed Inc. (NYSE:RMD – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday after William Blair upgraded the stock to a strong-buy rating. The company traded as high as $281.90 and last traded at $284.40, with a volume of 1796962 shares trading hands. The stock had previously closed at […] - 2025-08-06 02:48:56
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 16:05:36
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 13:25:08
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 12:46:35
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 12:34:59
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 10:57:35
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 10:16:48
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 08:11:00
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 06:37:59
Reviewing ResMed (NYSE:RMD) & Hybrid Energy (OTCMKTS:HYBE)
ResMed (NYSE:RMD – Get Free Report) and Hybrid Energy (OTCMKTS:HYBE – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership. Earnings & Valuation This table compares ResMed and Hybrid […] - 2025-08-04 04:55:10
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 04:42:34
Wall Street Zen Upgrades ResMed (NYSE:RMD) to Buy
ResMed (NYSE:RMD – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday. Other analysts have also recently issued reports about the stock. KeyCorp raised their price target on shares of ResMed from $274.00 to $298.00 and gave […] - 2025-08-04 04:14:56
ResMed (NYSE:RMD) Price Target Raised to $270.00 at Piper Sandler
ResMed (NYSE:RMD – Free Report) had its price objective increased by Piper Sandler from $248.00 to $270.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a neutral rating on the medical equipment provider’s stock. Other research analysts also recently issued research reports about the stock. Mizuho upped their target […] - 2025-08-04 03:04:46
Stocks Settle Sharply Lower on Economic Risks
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.60%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.96%. September E-mini S&P futures (ESU25 ) fell -1.67%, and September E-mini Nasdaq futures (NQU25... - 2025-08-04 01:35:23
Daily Dividend Report: AAPL,XOM,ITW,FIS,RMD
Apple's board of directors has declared a cash dividend of $0.26 per share of the Company's common stock. The dividend is payable on August 14, 2025 to shareholders of record as of the close of business on August 11, 2025. ExxonMobil declared a third-quarter dividend of $0.99 - 2025-08-01 13:43:45
After-Hours Earnings Report for July 31, 2025 : AAPL, AMZN, SYK, KLAC, MSTR, COIN, AJG, NET, RMD, MPWR, IR, LPLA
The following companies are expected to report earnings after hours on 07/31/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Apple Inc. (AAPL)is reporting for the quarter ending June 30, 2025. The computer company's consensus earnings per share fo - 2025-07-31 15:00:01
ResMed (NYSE:RMD) Stock Unloaded Rep. Kelly Morrison
Representative Kelly Morrison (D-Minnesota) recently sold shares of ResMed Inc. (NYSE:RMD). In a filing disclosed on June 18th, the Representative disclosed that they had sold between $1,001 and $15,000 in ResMed stock on June 4th. The trade occurred in the Representative’s “TRUST 5” account. Representative Kelly Morrison also recently made the following trade(s): Sold $1,001 […] - 2025-07-29 03:04:50
HighPoint Advisor Group LLC Has $498,000 Stake in ResMed Inc. (NYSE:RMD)
HighPoint Advisor Group LLC reduced its stake in shares of ResMed Inc. (NYSE:RMD – Free Report) by 18.5% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 2,095 shares of the medical equipment provider’s stock after selling 475 shares during the period. HighPoint Advisor Group LLC’s holdings […] - 2025-07-24 05:53:02
Kestra Private Wealth Services LLC Has $1.78 Million Position in ResMed Inc. (NYSE:RMD)
Kestra Private Wealth Services LLC reduced its holdings in ResMed Inc. (NYSE:RMD – Free Report) by 9.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,944 shares of the medical equipment provider’s stock after selling 799 shares during the period. Kestra Private Wealth […] - 2025-07-23 06:42:53
SBI Securities Co. Ltd. Sells 171 Shares of ResMed Inc. (NYSE:RMD)
SBI Securities Co. Ltd. trimmed its stake in ResMed Inc. (NYSE:RMD – Free Report) by 58.4% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 122 shares of the medical equipment provider’s stock after selling 171 shares during the period. SBI Securities Co. Ltd.’s holdings in […] - 2025-07-21 05:23:00
ResMed Inc. (NYSE:RMD) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lowered its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 2.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,116 shares of the medical equipment provider’s stock after selling 508 shares during […] - 2025-07-18 05:16:49
ResMed (NYSE:RMD) Rating Increased to Outperform at Royal Bank Of Canada
ResMed (NYSE:RMD – Get Free Report) was upgraded by analysts at Royal Bank Of Canada from a “sector perform” rating to an “outperform” rating in a report issued on Tuesday, MarketBeat reports. The brokerage presently has a $294.00 target price on the medical equipment provider’s stock, up from their previous target price of $255.00. Royal […] - 2025-07-17 05:00:49
ResMed Inc. (NYSE:RMD) Stake Increased by Ballentine Partners LLC
Ballentine Partners LLC boosted its stake in ResMed Inc. (NYSE:RMD – Free Report) by 6.3% during the 1st quarter, HoldingsChannel reports. The fund owned 1,782 shares of the medical equipment provider’s stock after buying an additional 105 shares during the period. Ballentine Partners LLC’s holdings in ResMed were worth $399,000 as of its most recent […] - 2025-07-16 10:44:50

iShares MSCI USA ESG Screened UCITS ETF USD (Acc) RMD holdings

DateNumber of RMD Shares HeldBase Market Value of RMD SharesLocal Market Value of RMD SharesChange in RMD Shares HeldChange in RMD Base ValueCurrent Price per RMD Share HeldPrevious Price per RMD Share Held
2025-09-18 (Thursday)44,189RMD holding increased by 120USD 12,076,412RMD holding increased by 102424USD 12,076,412120USD 102,424 USD 273.29 USD 271.71
2025-09-17 (Wednesday)44,069RMD holding increased by 150USD 11,973,988RMD holding increased by 1669USD 11,973,988150USD 1,669 USD 271.71 USD 272.6
2025-09-16 (Tuesday)43,919RMD holding increased by 240USD 11,972,319RMD holding increased by 127011USD 11,972,319240USD 127,011 USD 272.6 USD 271.19
2025-09-15 (Monday)43,679USD 11,845,308USD 11,845,308
2025-09-12 (Friday)43,599USD 11,777,834USD 11,777,834
2025-09-11 (Thursday)43,599USD 11,972,721USD 11,972,721
2025-09-10 (Wednesday)43,609USD 11,794,926USD 11,794,926
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RMD by Blackrock for IE00BFNM3G45

Show aggregate share trades of RMD

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY120 273.290* 243.16
2025-09-17BUY150 271.710* 243.01
2025-09-16BUY240 272.600* 242.85
2025-08-15BUY20 284.890* 242.40
2025-08-13BUY10 288.280* 242.15
2025-07-31BUY50 271.940* 241.76
2025-07-29BUY200 277.700* 241.36
2025-07-28BUY40 273.500* 241.19
2025-07-25BUY60 275.160* 241.00
2025-07-24BUY29 273.500* 240.81
2025-07-23BUY70 273.370* 240.63
2025-07-22BUY40 267.400* 240.48
2025-07-18BUY80 257.920* 240.26
2025-07-17BUY60 256.420* 240.17
2025-07-11BUY80 254.400* 239.84
2025-07-10BUY90 258.070* 239.74
2025-07-09BUY90 255.980* 239.64
2025-07-07SELL-60 256.410* 239.43 Profit of 14,366 on sale
2025-07-02SELL-250 255.880* 239.12 Profit of 59,779 on sale
2025-06-27BUY30 255.160* 238.90
2025-06-26BUY30 256.210* 238.79
2025-06-24SELL-140 255.910* 238.56 Profit of 33,398 on sale
2025-06-18BUY80 250.880* 238.19
2025-06-17BUY30 250.090* 238.12
2025-06-16SELL-41 251.680* 238.03 Profit of 9,759 on sale
2025-06-13BUY87 249.340* 237.95
2025-06-12SELL-50 252.210* 237.86 Profit of 11,893 on sale
2025-06-11BUY102 251.360* 237.76
2025-06-06BUY30 252.200* 237.47
2025-06-05BUY140 249.690* 237.39
2025-06-04BUY20 249.940* 237.30
2025-06-03SELL-10 247.050* 237.23 Profit of 2,372 on sale
2025-05-30BUY1,546 244.790* 237.13
2025-05-29BUY23 245.120* 237.07
2025-05-27BUY153 246.220* 236.95
2025-05-23BUY120 242.840* 236.86
2025-05-22BUY63 245.490* 236.79
2025-05-19BUY54 253.350* 236.51
2025-05-16BUY27 251.690* 236.40
2025-05-15SELL-18 248.580* 236.30 Profit of 4,253 on sale
2025-05-14BUY9 246.990* 236.22
2025-05-13BUY18 247.650* 236.13
2025-05-12BUY63 247.660* 236.04
2025-05-09SELL-45 245.040* 235.97 Profit of 10,618 on sale
2025-05-08BUY18 243.090* 235.91
2025-05-07BUY27 244.700* 235.84
2025-05-02BUY999 239.950* 235.71
2025-04-30BUY315 236.590* 235.70
2025-04-29BUY78 237.740* 235.68
2025-04-28BUY63 234.140* 235.69
2025-04-25BUY162 235.880* 235.69
2025-04-24SELL-189 236.100* 235.69 Profit of 44,545 on sale
2025-04-23BUY171 214.440* 235.88
2025-04-22BUY72 214.080* 236.07
2025-04-17BUY99 212.910* 236.73
2025-04-15BUY90 213.970* 237.17
2025-04-11BUY144 213.990* 237.61
2025-04-09BUY54 216.440* 238.08
2025-04-08BUY324 204.540* 238.41
2025-04-07BUY105 213.000* 238.66
2025-04-04SELL-144 205.170* 238.99 Profit of 34,415 on sale
2025-04-02BUY1,224 223.000* 239.16
2025-04-01BUY9 222.300* 239.33
2025-03-31BUY63 223.850* 239.49
2025-03-28BUY36 219.940* 239.69
2025-03-27BUY16 222.620* 239.87
2025-03-26BUY9 221.880* 240.06
2025-03-25BUY99 221.290* 240.26
2025-03-24BUY104 222.910* 240.45
2025-03-21SELL-36 219.700* 240.68 Profit of 8,665 on sale
2025-03-20BUY144 221.110* 240.90
2025-03-19BUY24 222.050* 241.11
2025-03-18BUY304 220.250* 241.35
2025-03-17BUY63 224.740* 241.54
2025-03-14BUY468 224.160* 241.74
2025-03-13BUY90 219.720* 242.00
2025-03-12SELL-450 220.220* 242.26 Profit of 109,016 on sale
2025-03-11SELL-333 225.790* 242.46 Profit of 80,738 on sale
2025-03-10BUY99 236.630* 242.53
2025-03-07BUY18 232.440* 242.65
2025-03-05BUY135 223.830* 242.89
2025-03-04BUY153 231.480* 243.03
2025-03-03BUY288 233.100* 243.16
2025-02-28BUY234 233.520* 243.28
2025-02-27SELL-45 231.280* 243.44 Profit of 10,955 on sale
2025-02-25BUY333 236.190* 243.66
2025-02-21BUY36 231.690* 244.02
2025-02-18SELL-81 230.580* 244.52 Profit of 19,806 on sale
2025-02-14SELL-549 232.980* 244.86 Profit of 134,428 on sale
2025-02-13BUY9 239.480* 244.94
2025-02-12BUY88 236.600* 245.07
2025-02-07SELL-14 236.940* 245.43 Profit of 3,436 on sale
2025-02-06BUY171 237.180* 245.57
2025-02-05BUY45 242.580* 245.61
2025-02-04BUY54 240.460* 245.70
2025-02-03BUY54 240.550* 245.79
2025-01-31BUY99 236.180* 245.96
2025-01-29SELL-9 252.860* 245.62 Profit of 2,211 on sale
2025-01-28SELL-81 249.940* 245.54 Profit of 19,889 on sale
2025-01-27SELL-144 254.700* 245.37 Profit of 35,333 on sale
2025-01-24BUY108 250.510* 245.27
2025-01-23BUY18 248.880* 245.20
2024-12-10BUY450 245.220* 245.20
2024-12-09BUY54 244.760* 245.21
2024-12-06SELL-135 241.410* 245.29 Profit of 33,114 on sale
2024-12-05SELL-9 239.410* 245.41 Profit of 2,209 on sale
2024-12-03BUY45 246.910* 245.37
2024-11-27SELL-54 249.330* 245.10 Profit of 13,235 on sale
2024-11-26BUY189 249.990* 244.85
2024-11-26BUY189 249.990* 244.85
2024-11-25BUY24 249.560* 244.59
2024-11-25BUY24 249.560* 244.59
2024-11-22SELL-16 243.780* 244.61 Profit of 3,914 on sale
2024-11-21SELL-45 243.600* 244.64 Profit of 11,009 on sale
2024-11-20SELL-18 241.550* 244.73 Profit of 4,405 on sale
2024-11-19BUY9 238.120* 244.94
2024-11-18BUY80 239.420* 245.11
2024-11-11BUY27 248.690* 244.79
2024-11-11BUY27 248.690* 244.79
2024-11-07BUY23 248.540* 243.88
2024-11-07BUY23 248.540* 243.88
2024-11-06BUY216 245.630* 243.73
2024-11-06BUY216 245.630* 243.73
2024-11-05BUY45 245.740* 243.54
2024-11-05BUY45 245.740* 243.54
2024-11-04BUY16 243.610* 243.53
2024-11-04BUY16 243.610* 243.53
2024-11-01BUY24 244.280* 243.44
2024-11-01BUY24 244.280* 243.44
2024-10-30SELL-54 243.020* 243.65 Profit of 13,157 on sale
2024-10-30SELL-54 243.020* 243.65 Profit of 13,157 on sale
2024-10-29SELL-162 244.400* 243.52 Profit of 39,450 on sale
2024-10-29SELL-162 244.400* 243.52 Profit of 39,450 on sale
2024-10-28SELL-63 246.830* 242.78 Profit of 15,295 on sale
2024-10-28SELL-63 246.830* 242.78 Profit of 15,295 on sale
2024-10-21SELL-9 240.050* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RMD

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19144,8610212,35968.2%
2025-09-18147,389242198,80774.1%
2025-09-17231,9927298,71077.7%
2025-09-16223,33274290,89676.8%
2025-09-15189,742347243,08778.1%
2025-09-12222,5770315,01270.7%
2025-09-11150,6470264,30057.0%
2025-09-10346,75565459,49375.5%
2025-09-09174,7680220,62379.2%
2025-09-08157,598225276,36557.0%
2025-09-05347,50915402,25786.4%
2025-09-04340,67316443,17376.9%
2025-09-03421,481110699,42960.3%
2025-09-02278,611184414,44167.2%
2025-08-29281,44596338,84283.1%
2025-08-28356,879100411,22386.8%
2025-08-27254,5790345,28173.7%
2025-08-26131,4271223,99258.7%
2025-08-25172,3716295,18258.4%
2025-08-22162,8381218,28274.6%
2025-08-21223,4759303,09273.7%
2025-08-20212,0262293,16372.3%
2025-08-19178,9140262,25268.2%
2025-08-18120,8240165,86372.8%
2025-08-15181,17524213,57484.8%
2025-08-14263,96718293,74789.9%
2025-08-13237,6235298,38979.6%
2025-08-12204,8330260,99178.5%
2025-08-11226,6530324,10469.9%
2025-08-08155,82815217,68471.6%
2025-08-07273,5580346,70778.9%
2025-08-06307,2421388,75779.0%
2025-08-05642,8140756,16585.0%
2025-08-04623,6870710,37087.8%
2025-08-01652,136500773,70284.3%
2025-07-31408,8710497,96882.1%
2025-07-30562,6870703,28780.0%
2025-07-29428,61310511,17883.8%
2025-07-28306,7028395,75377.5%
2025-07-25322,1190417,10877.2%
2025-07-24213,7790276,44177.3%
2025-07-23308,095189408,32975.5%
2025-07-22404,856178562,17772.0%
2025-07-21214,6290289,94874.0%
2025-07-18174,143180296,97958.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.